We help innovative medicines on their way to patients – with clear strategy, solid evidence and well-timed decisions.
Focused expertise in the areas that decide whether, and when, a new treatment becomes available.
A clear plan for how and when your product reaches patients – grounded in local rules.
Dossiers that answer the questions assessors will ask, and steady guidance until a decision is made.
Cost-effectiveness and budget impact models and calculators that are transparent, robust and easy to defend.
Real-world evidence and local data turned into credible inputs – epidemiology, treatment patterns and resource use.
Value arguments, pricing scenarios and agreements that work for both the payer and the manufacturer.
Preparing national strategy alongside the joint clinical assessment, so the two fit together.
Tymly comes from timely. Good access work is not only about getting a yes – it is about getting it in time.
We start with your product, your goals and your deadlines – and map what stands in the way.
Together with you, we build the evidence, models and documents the decision really needs.
We stay with you through assessment and negotiation until the treatment is available.
Tymly brings together experts in health technology assessment, health economics and market access. We work closely with our clients, keep teams small and stay personally involved – because access projects depend on judgement as much as on method.
Tell us about your product and timelines. We will get back to you within one business day.